documents: FDA-1992-N-0056-0017
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-1992-N-0056-0017 | FDA | FDA-1992-N-0056 | Notice of Final Rule re Distribution of Blood Derivatives by Registered Blood Establishments Qualify as Health Care Entities; Prescription Drug Marketing Act of 1987; Prescription Drug Amendments of 1992; Delay of Applicability Date | Notice | Notice of Final Rule | 2006-11-13T05:00:00Z | 2006 | 11 | 2006-11-09T05:00:00Z | 2016-11-08T14:39:45Z | 0 | 0 | 090000648052c009 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref